Literature DB >> 28126263

Treponema pallidum flagellins elicit proinflammatory cytokines from human monocytes via TLR5 signaling pathway.

Man Xu1, Yafeng Xie2, Chuanhao Jiang3, Yongjian Xiao4, Xingxing Kuang1, Yating Wen1, Yuan Tan1, Manyi Tan1, Feijun Zhao1, Tiebing Zeng1, Yimou Wu5.   

Abstract

The tissue damage caused by syphilis infection may be associated with inflammation. However, the virulence factors of Treponema pallidum are still unclear, nor are the molecular mechanisms for leading to the productions of proinflammatory cytokines. Flagellin, a classic pathogen-associated molecular pattern (PAMP), is a potent immunogen that induces inflammation. In the present study, we have demonstrated that stimulations of human monocytes with Treponema pallidum FlaB1, FlaB2, and FlaB3 result in the up regulation of interleukin (IL)-6 and IL-8. Moreover, silencing of the Toll-like receptor 5 (TLR5) gene by using small interfering RNA was found to abrogate the T. pallidum flagellins-induced IL-6 and IL-8 expressions. Similarly, transfection with the dominant negative plasmid encoding MyD88 (pDeNy-hMyD88) was also giving rise to the down regulation of IL-6 and IL-8. We further investigated the relative contributions of mitogen-activated protein kinase (MAPK) and nuclear factor κB (NF-κB) signaling to transcriptions and translations of IL-6 and IL-8. Western Blot and immuno fluorescence experiments revealed that flagellins-mediated IL-6 and IL-8 expressions are heavily dependent on ERK, p38, and NF-κB. In addition, inhibitions of p38 kinase, ERK, and NF-κB were found to attenuate the productions of IL-6 and IL-8. Taken together, our results indicate that T. pallidum flagellins can upregulate IL-6 and IL-8 generations via TLR5 and MAPK/NF-κB signaling pathways in THP-1 cells, which will improve our understanding of the pathogenesis of T. pallidum.
Copyright © 2017 Elsevier GmbH. All rights reserved.

Entities:  

Keywords:  Flagellin; Human monocytes; Inflammation; TLR5 signaling; Treponema pallidum

Mesh:

Substances:

Year:  2017        PMID: 28126263     DOI: 10.1016/j.imbio.2017.01.002

Source DB:  PubMed          Journal:  Immunobiology        ISSN: 0171-2985            Impact factor:   3.144


  6 in total

1.  Immunogenicity and protective efficacy against Treponema pallidum in New Zealand rabbits immunized with plasmid DNA encoding flagellin.

Authors:  Kang Zheng; Man Xu; Yongjian Xiao; Haodang Luo; Yafeng Xie; Jian Yu; Manyi Tan; Yumeng Li; Feijun Zhao; Tiebing Zeng; Yimou Wu
Journal:  Emerg Microbes Infect       Date:  2018-11-07       Impact factor: 7.163

2.  Combination of the neutrophil to lymphocyte ratio and serum toluidine red unheated serum test titer as a predictor of neurosyphilis in HIV-negative patients.

Authors:  Caifeng He; Xianjin Shang; Wenbei Liu; Shouyun Hang; Jingtao Chen; Chao Ci
Journal:  Exp Ther Med       Date:  2021-01-07       Impact factor: 2.447

3.  Chlamydia psittaci Plasmid-Encoded CPSIT_P7 Elicits Inflammatory Response in Human Monocytes via TLR4/Mal/MyD88/NF-κB Signaling Pathway.

Authors:  Qian Chen; Yumeng Li; Xiaoliang Yan; Zhenjie Sun; Chuan Wang; Shuangquan Liu; Jian Xiao; Chunxue Lu; Yimou Wu
Journal:  Front Microbiol       Date:  2020-12-03       Impact factor: 5.640

4.  YTHDF1 Negatively Regulates Treponema pallidum-Induced Inflammation in THP-1 Macrophages by Promoting SOCS3 Translation in an m6A-Dependent Manner.

Authors:  Zhijia Li; Muzhou Teng; Yinbo Jiang; Litian Zhang; Xi Luo; Yuhui Liao; Bin Yang
Journal:  Front Immunol       Date:  2022-04-04       Impact factor: 8.786

5.  IL-27 amplifies cytokine responses to Gram-negative bacterial products and Salmonella typhimurium infection.

Authors:  C Petes; N Odoardi; S M Plater; N L Martin; K Gee
Journal:  Sci Rep       Date:  2018-09-12       Impact factor: 4.379

6.  The N-terminal D1 domain of Treponema pallidum flagellin binding to TLR5 is required but not sufficient in activation of TLR5.

Authors:  Man Xu; Yafeng Xie; Manyi Tan; Kang Zheng; Yongjian Xiao; Chuanhao Jiang; Feijun Zhao; Tiebing Zeng; Yimou Wu
Journal:  J Cell Mol Med       Date:  2019-09-07       Impact factor: 5.310

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.